INTERNATIONAL PATENT: INIMMUNE CORP. FILES APPLICATION FOR "INTRANASAL ADMINISTRATION OF TOLL-LIKE RECEPTOR 4 AGONISTS FOR TREATING ALLERGIC RHINITIS AND OTHER DISEASES AND CONDITIONS"

GENEVA, Nov. 25 -- INIMMUNE CORP. (1121 East Broadway, Ste 121Missoula, Montana 59802) filed a patent application (PCT/US2025/029048) for "INTRANASAL ADMINISTRATION OF TOLL-LIKE RECEPTOR 4 AGONISTS FOR TREATING ALLERGIC RHINITIS AND OTHER DISEASES AND CONDITIONS" on May 13, 2025. With publication no. WO/2025/240407, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WALSH, Lois M. (c/o INIMMUNE CORP.1121 East Broadway, Ste 121Missoula, Montana 59802)

Abstract: Formulations comprising a Toll-like receptor 4 (TLR4) agonist, 1...